 Clinical Study
November 15, 2024
Breakthroughs in Chronic Hepatitis B Treatment: Barinthus Bio s Promising Phase 2b Trial Results Chronic Hepatitis B (CHB) continues to be a major global health challenge, with millions affected worldwide. New therapeutic approaches are urgently needed to combat the disease and Barinthus Bio is at the forefront wit...
|
Clinical Study
November 15, 2024
Promising Advances in HBV Treatment: Arbutus Imdusiran and Interferon Combine for Transformative Patient Outcomes In recent developments within the realm of hepatitis B virus (HBV) treatment, Arbutus Biopharma s investigational therapeutic, Imdusiran, has demonstrated significant efficacy when combined with a shor...
|
Clinical Study
November 15, 2024
Altimmune Inc. a biopharmaceutical company focused on developing innovative products to treat liver diseases and other metabolic disorders, recently presented pivotal findings at The Liver Meeting 2024. These findings highlight the promising effects of their investigational therapeutic, pemvidutide, on lipid profile...
|
|
 Business Update
November 15, 2024
Oscar Health Expands to New Frontiers: New Jersey and Texas Selections for 2025 Oscar Health, Inc. (NYSE: OSCR), a trailblazer in the healthcare technology sector, has made a strategic announcement set to reshape the Affordable Care Act (ACA) marketplace in 2025. With its eyes on the horizons of New Jersey and Texa...
 Business Update
November 15, 2024
Unlocking New Horizons: Gilead’s Livdelzi Shines in PBC Treatment Amid Competitive Market Dynamics In the evolving landscape of hepatology, Gilead Sciences, Inc. (Nasdaq: GILD) continues to assert its presence, particularly regarding the management of primary biliary cholangitis (PBC) with its investigational drug...
|
|
Our most Popular Articles
|
Business Update
July 29, 2024
In a significant advancement for diabetes management, Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. (Nasdaq: DXCM) have announced that the t:slim X2 insulin pump integrated with the latest Dexcom G7 Continuous Glucose Monitoring (CGM) system has received authorization for sale from Health Canada. This i...
|
Business Update
December 12, 2024
Enhancing Customer Experience: Descope and 8x8 Join Forces to Fortify Security and Efficiency In an era where digital connectivity is paramount, the seamless integration of secure, efficient systems is essential to delivering exceptional customer experiences. Emphasizing this commitment to innovation, 8x8, Inc. (NAS...
|
Management Changes
September 5, 2024
Vimeo Appoints Robert Petrocelli as Company s First Chief Product & Technology Officer
Vimeo, the leading video experience platform for creators and enterprises, has made a significant move towards enhancing its technological capabilities by appointing industry veteran Robert (Bob) Petrocelli as the Chief Produ...
|
|
|
Company News
|
Clinical Study
November 15, 2024
Promising Advances in HBV Treatment: Arbutus Imdusiran and Interferon Combine for Transformative Patient Outcomes In recent developments within the realm of hepatitis B virus (HBV) treatment, Arbutus Biopharma s investigational therapeutic, Imdusiran, has demonstrated significant efficacy when combined with a shor...
|
Clinical Study
November 15, 2024
Altimmune Inc. a biopharmaceutical company focused on developing innovative products to treat liver diseases and other metabolic disorders, recently presented pivotal findings at The Liver Meeting 2024. These findings highlight the promising effects of their investigational therapeutic, pemvidutide, on lipid profile...
|
Clinical Study
November 15, 2024
Akero Therapeutics Presents Promising Results from Phase 2b HARMONY Study at AASLD The Liver Meeting 2024 Akero Therapeutics has recently announced its decision to present new insights from its Phase 2b HARMONY study at the 75th Annual American Association for the Study of Liver Diseases (AASLD) The Liver Meeting 20...
|
|
|
Company News
 Business Update
November 15, 2024
|
Company News
 Business Update
November 15, 2024
|
Company News
 Business Update
November 15, 2024
|
More Company News
|
Business Update
November 15, 2024
|
Announcement
November 15, 2024
|
Announcement
November 15, 2024
|
Product Service News
November 15, 2024
|
Product Service News
November 15, 2024
|
Business Update
November 15, 2024
|
Business Update
November 15, 2024
|
Product Service News
November 15, 2024
|
Contract
November 15, 2024
|
Product Service News
November 15, 2024
|
|
|
|
Related News
|
Partnership
|
Business Update
|
|
Stocks
|
Business Update
|
Business Update
|
Management Announcement
|
|
|
|
Business News
|
|
Business Update
Oscar Health Expands to New Frontiers: New Jersey and Texas Selections for 2025 Oscar Health, Inc. (NYSE: OSCR), a trailblazer in the healthcare technology sector, has made a strategic announcement set to reshape the Affordable Care Act (ACA) marketplace in 2025. With its eyes on the horizons of New Jersey and Texa...
|
|
Business Update
Unlocking New Horizons: Gilead’s Livdelzi Shines in PBC Treatment Amid Competitive Market Dynamics In the evolving landscape of hepatology, Gilead Sciences, Inc. (Nasdaq: GILD) continues to assert its presence, particularly regarding the management of primary biliary cholangitis (PBC) with its investigational drug...
|
 Business Update
Title : A Ray of Hope: New Combinations Show Promise in Battling Chronic Hepatitis BIn the quest for effective treatments against chronic hepatitis B, researchers and patients alike have long awaited breakthroughs that could lead to curative options. Vir Biotechnology, Inc. may have just delivered some exciting news...
|
 Equity Market Information
In-Depth Analysis: Syntec Optics and Its Recent Financial Developments Overview Syntec Optics (Nasdaq: OPTX), headquartered in Rochester, New York, has emerged as a pivotal player in the production of mission-critical optics for sectors such as defense, biomedical, communications, and consumer markets. Recently, ...
|
 Clinical Study
Breakthroughs in Chronic Hepatitis B Treatment: Barinthus Bio s Promising Phase 2b Trial Results Chronic Hepatitis B (CHB) continues to be a major global health challenge, with millions affected worldwide. New therapeutic approaches are urgently needed to combat the disease and Barinthus Bio is at the forefront wit...
|
Our Most Popular Articles
|
 Business Update
In a significant advancement for diabetes management, Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. (Nasdaq: DXCM) have announced that the t:slim X2 insulin pump integrated with the latest Dexcom G7 Continuous Glucose Monitoring (CGM) system has received authorization for sale from Health Canada. This i...
|
 Business Update
Enhancing Customer Experience: Descope and 8x8 Join Forces to Fortify Security and Efficiency In an era where digital connectivity is paramount, the seamless integration of secure, efficient systems is essential to delivering exceptional customer experiences. Emphasizing this commitment to innovation, 8x8, Inc. (NAS...
|
 Management Changes
Vimeo Appoints Robert Petrocelli as Company s First Chief Product & Technology Officer
Vimeo, the leading video experience platform for creators and enterprises, has made a significant move towards enhancing its technological capabilities by appointing industry veteran Robert (Bob) Petrocelli as the Chief Produ...
|
More News
|
 Clinical Study
Promising Advances in HBV Treatment: Arbutus Imdusiran and Interferon Combine for Transformative Patient Outcomes In recent developments within the realm of hepatitis B virus (HBV) treatment, Arbutus Biopharma s investigational therapeutic, Imdusiran, has demonstrated significant efficacy when combined with a shor...
|
 Clinical Study
Altimmune Inc. a biopharmaceutical company focused on developing innovative products to treat liver diseases and other metabolic disorders, recently presented pivotal findings at The Liver Meeting 2024. These findings highlight the promising effects of their investigational therapeutic, pemvidutide, on lipid profile...
|
 Clinical Study
Akero Therapeutics Presents Promising Results from Phase 2b HARMONY Study at AASLD The Liver Meeting 2024 Akero Therapeutics has recently announced its decision to present new insights from its Phase 2b HARMONY study at the 75th Annual American Association for the Study of Liver Diseases (AASLD) The Liver Meeting 20...
|
|
Business Update
In a significant advancement for aviation technology, Teledyne Controls, a subsidiary of Teledyne Technologies (NYSE: TDY), has announced the certification of its next-generation enhanced Airborne Data Loader (eADL XS) for use on the Boeing 737NG aircraft series. This breakthrough positions Teledyne at the forefront...
|
|
Business Update
The Reinsurance Group of America, Incorporated (RGA), a forerunner in the global life and health reinsurance landscape, has made significant strides recently with two pivotal announcements that leverage innovation and strategic partnerships to enhance its market presence. The launches not only underscore RGA s commi...
|
|
Business Update
In a remarkable stride towards catering to the evolving needs of modern homebuyers, KB Home (NYSE: KBH), renowned as one of the largest and most trusted homebuilders in the United States, has revealed the grand opening of its latest residential communities: Hamilton Park in Elk Grove, California, and Rhythm in Long ...
|
 Business Update
Rays of Revival: The Real Estate Resurgence Defying Economic Gloom As autumn leaves paint the streets with hues of amber and gold, something brighter seems to be glinting beneath the economic overcast that has shrouded the housing sector. House hunters across America are dipping their toes back into the market with ...
|
 Announcement
Bridging Realities: The Rise of Neural Interfaces in Wearable TechnologyIn the rapidly evolving landscape of wearable technology, one company has distinguished itself with groundbreaking innovation: Wearable Devices Ltd. a leader in AI-based gesture control technology. Headquartered in Yokneam Illit, Israel, the c...
|
 Announcement
In an era increasingly defined by technological innovation, WISeSat.Space is making waves not only for its pioneering advancements in satellite technology but also for its forays into the realms of blockchain and cryptocurrency. Recently spotlighted on Swiss Radio Television, WISeSat.Space is gaining recognition fo...
|
 Product Service News
In a significant move towards sustainable technology practices, Lucas GC Limited (NASDAQ: LGCL) has announced its contribution to the establishment of three crucial industry standards for green intelligent computing in China. This initiative reflects Lucas GC s commitment to pioneering innovative solutions in the Pl...
|
 Product Service News
Fortinet s Strategic Expansion: A New Innovation Hub in Atlanta and Global SASE Solutions In a strategic move to bolster its global presence, Fortinet, a leading cybersecurity company, has announced the establishment of a new company-owned Innovation Hub in Atlanta. This development signals the company s commitment ...
|
 Business Update
In the rapidly evolving world of green data centers, Soluna Holdings Inc. is distinguishing itself as an agile competitor, marked by impressive revenue growth despite difficult market conditions. As revealed in the company s third quarter financial results for 2024, Soluna is making strides in its strategic initiati...
|
 Business Update
Albany International Corp. (NYSE: AIN), a leading advanced textiles and materials processing company, has announced a strategic shift in its global manufacturing operations designed to optimize efficiencies and streamline production capacity. The company revealed plans to consolidate its manufacturing footprint, particularly focusing on the restructuring of its European operations.Heimbach Switzerland AG, a key affiliate of Albany International Corp. has disclosed its proposal to discontinue its manufacturing operations in Olten, Switzerland. This decision is aimed at transferring production activities to other existing Heimbach GmbH facilities that are better aligned with the company s strategic s and operational efficiencies. While a significant move, the company is committed to adhering to local regulations and ensuring that the transition process is handled sensitively and in close consultation with employee representatives.
|
 Product Service News
By CSIMarket.com In a strategic move that underscores the burgeoning landscape of life science and office space in the greater Philadelphia region, Brandywine Realty Trust (NYSE: BDN) has announced the full lease-up of its high-profile development, 250 Radnor. The recent signing of a 119,000-square-foot lease ...
|
 Contract
SIMPPLE Ltd. Secures $400,000 Contract for Autonomous Cleaning Robots at Singapore International Airport Terminal In a significant advancement for both the facilities management and robotics sectors, SIMPPLE Ltd. (Nasdaq: SPPL) has announced its acquisition of a lucrative contract valued at $400,000 to deploy its st...
|
 Product Service News
In a strategic move to enhance its footprint in the New York City metropolitan area, Toll Brothers, Inc. (NYSE: TOL) has announced a joint venture with Daiwa House, one of Japan s leading real estate and construction firms, to develop a new luxury condominium community along the Hudson River waterfront. The project,...
|
|
|
|
|
